Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (LNTH) Stock Overview

Explore Lantheus Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LNTH●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$99.97
$0.27(0.27%)
U.S. Market opens in 62h 47m

Lantheus Holdings, Inc. (LNTH)

Meyka AI Score

Z

Key Financials

Market Cap6.5B
P/E Ratio23.80
EPS (TTM)$5.95
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$100.83
3 Months$87.35
1 Year Target$79.37

LNTH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Lantheus Holdings, Inc. (NASDAQ: LNTH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Lantheus Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LNTH on the NASDAQ shows an RSI of 42.58, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $79.37 for the NASDAQ listing.

Key metrics behind Lantheus Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of 23.80 and a market capitalization of 6.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LNTH on the NASDAQ.

Price Performance (NASDAQ: LNTH)

1-Day Change
-0.27%
5-Day Change
-0.97%
1-Month Change
-7.39%
3-Month Change
5.82%
6-Month Change
35.33%
Year-to-Date (YTD) Change
50.22%
1-Year Change
68.98%
3-Year Change
48.50%
5-Year Change
287.78%
All-Time (Max) Change
1376.66%

Contact Information

https://www.lantheus.com
978 671 8001
201 Burlington Road, Bedford, MA, 01730

Company Facts

11,930 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions